Latest Commercialisation News

St George Mining reports exceptional high-grade rare earth and niobium mineralisation at its Araxá Project in Brazil, alongside a strategic US partnership and a significant capital raise to fuel expansion.

Kinetiko Energy has reported record gas flow rates from its Brakfontein test wells, renewed critical exploration rights, and signed a joint venture to develop a pilot LNG plant, marking a significant step towards commercial gas production in South Africa.

Macarthur Minerals bolstered its financial position through a nearly A$2 million entitlement offer and strengthened governance with a key board appointment, setting the stage for advancing its Lake Giles Iron Ore Project.

Provaris Energy has advanced its hydrogen and carbon dioxide storage technologies through strategic partnerships and a new Norwegian fabrication facility, setting the stage for commercialisation in European energy markets.

High-Tech Metals has made significant strides in advancing its Mt Fisher and Mt Eureka gold projects, completing drilling and securing key approvals to fast-track production. Strategic joint ventures and a strengthened leadership team position the company for near-term growth.

Strategic Elements Ltd has marked a key milestone by successfully fabricating Energy Ink™ prototype cells in a commercial setting, while expanding its artificial intelligence ventures and maintaining a robust financial position.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.

Cynata Therapeutics is on track to deliver key clinical trial results in mid-2026 while maintaining a solid cash runway supported by an imminent R&D tax rebate and equity facility.

Santana Minerals reports robust progress on its Bendigo-Ophir Gold Project with an updated Pre-Feasibility Study, strategic land acquisitions, and a substantial capital raise, positioning the project for development in 2026.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.

NoviqTech Limited has launched Fuel Central for sustainable fuels traceability and established Quantum Intelligence Pty Ltd to advance quantum computing and AI applications, backed by a $1.08 million placement. The company also refreshed its board and expanded its international footprint.